A method and verification system for verifying pharmaceuticals packaged within a pouch using a pharmacy packaging system. The method includes activating a first light source to illuminate the pharmaceutical pouch, capturing a first image of the pharmaceutical pouch while illuminated by the first light source, activating a second light source to illuminate the pharmaceutical pouch, and capturing a second image of the pharmaceutical pouch while illuminated by the second light source. The method further includes generating a third image based on the first image and the second image, generating a dashboard to simultaneously display first images, second images, and third images from a plurality of pharmaceutical pouches, providing a number of pills indication of a number of pills detected in the pouch against a number of pills expected in the pouch, and displaying the dashboard.

A comestible dosage form article, in the form of a hard capsule, for administration to a target subject, the dosage form comprising at least one body and at least one cap telescopically engageable with the body, the cap and the body being separable such to allow dispensing of a contents therefrom. The capsule comprising a sensory trigger over at least a portion of the outer surface of the capsule arranged to provide a visual, taste, and/or tactile deterrence to ingestion thereof.

Methods and systems are provided for tracking and guiding a patient's clinically directed medication usage. Medicaments are placed in secure passive packaging that must be unlocked to enable dispensing of a dose or a set of doses. This packaging is designed to be difficult to open manually, and instead is designed to dispense only when used in combination with an unlocking device. The unlocking device is a separate device containing electronics, mechatronics or both, to unlock and dispense from the packaging and to track and guide usage. Together, the secure container and the unlocking device track medication usage, deter an excessive rate of patient usage, and deter unauthorized access to medication.

A opioid taper regimen, and its method of manufacture, for use in a method of opioid reduction leading to abstinence. Said regimen is administered within the range of 2 to 4 years, or more. The regimen comprises novel approaches to common problems encountered during tapers of low dose opioid addiction. The reduction regimen is generally linear; reduces the dosage level once per week; doses every six hours; reduces doses by steps in the range of about 0.001 to 0.0500 mg; has, near the end, ten weeks of doses of about 0.0025 mg buprenorphine q.i.d.; followed by four or more weeks of placebos. Instructions for manufacture of doses that differ by 0.0025 mg and 0.0050 mg buprenorphine are specified.

Techniques are provided for intelligent and secure dispensing of medication to a patient. A methodology implementing the techniques according to an embodiment includes receiving a pill vial into a receptacle of a base unit of a pill dispensing device. The method also includes engaging a locking mechanism to secure the pill vial in the base unit until a release condition is satisfied. The method further includes scanning a label on the pill vial to record a prescription identifier and a dosage schedule, and to register the prescription for usage tracking. The method further includes monitoring patient usage of the prescription based on a count of removals of the pill vial from the receptacle and a timing of the removals and alerting the patient of a missed dose based on the dosage schedule and on detection of an elapsed time since a previous removal of the pill vial from the receptacle.

Apparatus, systems and methods are disclosed relating to certain aspects of blood processing, collecting or storing, including method and system for automated authentication, processing device with scanner, blood container with two dimensional barcode, blood collection containers, blood container label and related tracking method, integrated container system, and processing device with sterile connection device.

Aspects and embodiments of the present invention generally include a device for patient self-administration of a prescribed medication. The total quantity of doses to be contained in the device, the quantity of prescribed medication comprising each individual dose, and the dosing schedule, collectively referred to as prescription parameters, are determined and controlled solely by a health care provider. In accordance with a prescribed dosing schedule, the device makes available for administration the precise quantity of prescribed medication constituting an individual dose. Patient access to the medication as well as patient control of the device is limited solely to the aspects of the device necessary to administer the available dose. The device also has a monitored subassembly which detects and transmits relevant device information to a remote management system accessible to the HCP, including detected attempts to alter, access, control or otherwise tamper with the device beyond its prescribed use.

An intradermal fluid delivery device that uses a processor controlled electromechanical delivery mechanism is provided. An air pump pushes fluid containing medication or saline from a fluid compartment through a microneedle array into a person's skin. The processor repeatedly turns the air pump on or off, for the fluid to gradually be injected into the person's skin. The processor may be configured to control the total fluid delivery time as well as the granularity of the fluid delivery. The total fluid delivery time may be set to T, and the time period T may be divided into smaller periods t.sub.1 to t.sub.n, where the fluid may be administered in a period t1, the fluid delivery may then be stopped for a period t2, followed by another fluid delivery period, etc. The periods t1 to tn may be the same or of different lengths.

Apparatus, systems and methods are disclosed relating to certain aspects of blood processing, collecting or storing, including method and system for automated authentication, processing device with scanner, blood container with two dimensional barcode, blood collection containers, blood container label and related tracking method, integrated container system, and processing device with sterile connection device.

Apparatus and associated software and methods for improving medication adherence. A connected medication dispenser includes a robotic arm adapted to deliver a prescribed medication dose to a patient in their home, and software and sensors that analyze the patient's compliance, communicate with external health sensors to monitor the patient's response to the dose, and communicate with external servers to send the result of providing the medication dose to the patient. In an illustrative example, the patient may be a chronic, acute, or terminal illness patient, and the results may be communicated with physicians, payers, caregivers, a pharmacy, and/or the patient's electronic health record. The flow of information may allow the physician or caregiver to offer real-time adjustments to the medication type, dose, and schedule to provide improved therapeutic outcomes.